DHR
DANAHER CORP /DE/
NYSE: DHR · Washington, DC · Industrials
$191.50-1.00 (-0.52%)Closed
Market Cap$134.61B
Cash$5.69Bmost recent
Runwayprofitable
P/E (TTM)37.9EPS $5.05
52-Wk Range$161.57 – $241.04
Avg Volume4.3M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$191.50-28.2%
Pipeline

Drug candidates sponsored by DANAHER CORP /DE/ · ClinicalTrials.gov

0 drugs · 0 trials
No trials found for this sponsor.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for DHR. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.